Effects of chronic Δ9-tetrahydrocannabinol on rat midbrain dopamine neurons: An electrophysiological assessment

Neuropharmacology

Volumn 39, Issue 3, 2000, Pages 391-398

  Wu, Xiaofang ^a   French, Edward D ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Delta 9 tetrahydrocannabinol; Electrophysiology; Marijuana; Substantia nigra; Ventral tegmental area

Indexed keywords

CANNABINOID RECEPTOR; CANNABIS; DRONABINOL; DOPAMINE; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CATALEPSY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; LOCOMOTION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ACTION POTENTIAL; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; BODY TEMPERATURE; CATALEPSY; DOPAMINE; MALE; MOTOR ACTIVITY; NEURONS; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TETRAHYDROCANNABINOL; VENTRAL TEGMENTAL AREA;

EID: 0033622131     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00140-9     Document Type: Article

References (31)

1. Bunney B.S., Walters J.R., Roth R.H., Aghajanian G.K. Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. Journal of Pharmacology and Experimental Therapeutics. 185:1973;560-571.
2. Cargo S. Increases in teen drug use appear to level off. NIDA Notes. 13:1998;10-11.
3. Costall B., Olley J.E. Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. Neuropharmacology. 10:1971;297-306.
4. De Fonseca R.F., Gorriti M.A., Fernandez-Ruiz J.J., Palomo T., Ramos J. Downregulation of rat brain cannabinoid binding sites after chronic Δ-9-tetrahydrocannabinol treatment. Pharmacology, Biochemistry and Behavior. 47:1994;33-40.
5. Dewey W.L. Cannabinoid pharmacology. Pharmacological Reviews. 38:1986;151-178.
6. French E.D. Δ9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neuroscience Letters. 226:1997;159-162.
7. French E.D., Vantini G. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants. Psychopharmacology. 82:1984;83-88.
8. French E.D., Mura A., Wang T. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in Rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse. 13:1993;108-116.
9. French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. NeuroReport. 8:1997;649-652.
10. Gardner E.L., Lowinson J.H. Marijuana's interaction with brain reward systems: update 1991. Pharmacology, Biochemistry and Behavior. 40:1991;571-580.
11. Gessa G., Melis M., Muntoni A., Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology. 341:1998;39-44.
12. Gonon F.G., Buda M.J. Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience. 14:1985;765-774.
13. Gough A.L., Olley J.E. Catalepsy induced by intrastriatal injections of delta-9-THC and 11-OH-9-THC in the rat. Neuropharmacology. 17:1978;137-144.
14. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. Journal of Neuroscience. 4:1984;2877-2890.
15. Harris R.T., Waters W., McLendon D. Evaluation of reinforcing capability of delta 9-THC in rhesus monkeys. Psychopharmacology. 37:1974;23-39.
16. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., DeCosta B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience. 11:1991;563-583.
17. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
18. Mansbach R.S., Nicholson K.L., Martin B.R., Balster R.L. Failure of Δ9-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behavioral Pharmacology. 5:1994;210-225.
19. Martellotta M.C., Cossu G., Fattore L., Gessa G.L., Fratta W. Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience. 85:1998;327-330.
20. Miller A.S., Walker J.M. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. European Journal of Pharmacology. 279:1995;179-185.
21. Navarro M., Fernandez-Ruiz J.J., De Miguel R., Hernandez M.L., Cebeira M., Ramos J.A. Motor disturbances induced by an acute dose of Δ9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacology, Biochemistry and Behavior. 45:1993;291-298.
22. Perez-Reyes M., White W.R., McDonald S.A., Hicks R.E., Jeffcoat A.R., Cook C.E. The pharmacologic effects of dialy marijuana smoking in humans. Pharmacology, Biochemistry and Behavior. 40:1991;691-694.
23. Pertwee R., Wickens A. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology. 30:1991;237-244.
24. 9-tetrahydrocannabinol. Pharmacology, Biochemistry and Behavior. 51:1995;731-737.
25. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. NeuroReport. 5:1994;2493-2496.
26. Rubino T., Patrini G., Parenti M., Massi P., Parolaro D. Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Molecular Brain Research. 44:1997;191-197.
27. 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission. Pharmacology, Biochemistry and Behavior. 33:1989;397-400.
28. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. Journal of Neuroscience. 16:1996;4322-4334.
29. Sim L., Hampson R.E., Deadwyler S.A., Childers S.R. Effects of chronic treatment with Δ9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgS autoradiography in rat brain. Journal of Neuroscience. 16:1996;8057-8066.
30. Szabo B., Dorner L., Pfreundtner C., Norenberg W., Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience. 85:1998;395-403.
31. Volkow N.D., Gillespie H., Mullani N., Tancredi L., Grant C., Valentine A., Hollister L. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatric Research: Neuroimaging. 67:1996;29-38.